EWA
CRNX icon

EverSource Wealth Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

EverSource Wealth Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.52K Sell
97
-13
-12% -$581 ﹤0.01% 3422
2025
Q4 		$5.12K Buy
110
+43
+64% +$1.91K ﹤0.01% 3109
2025
Q3 		$2.79K Sell
67
-36
-35% -$1.15K ﹤0.01% 3402
2025
Q2 		$2.96K Buy
103
+32
+45% +$988 ﹤0.01% 3356
2025
Q1 		$2.38K Sell
71
-16
-18% -$598 ﹤0.01% 2849
2024
Q4 		$4.45K Buy
87
+10
+13% +$559 ﹤0.01% 2405
2024
Q3 		$3.93K Buy
77
+10
+15% +$516 ﹤0.01% 2323
2024
Q2 		$3.56K Buy
67
+33
+97% +$1.52K ﹤0.01% 2340
2024
Q1 		$1.49K Sell
34
-85
-71% -$3.33K ﹤0.01% 2463
2023
Q4 		$4.23K Buy
119
+78
+190% +$2.39K ﹤0.01% 1920
2023
Q3 		$1.22K Buy
+41
New +$845 ﹤0.01% 2144

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return